chr5-32710680-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000506712.1(NPR3):n.27G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000584 in 1,540,660 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.00036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00061 ( 11 hom. )
Consequence
NPR3
ENST00000506712.1 non_coding_transcript_exon
ENST00000506712.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.106
Genes affected
NPR3 (HGNC:7945): (natriuretic peptide receptor 3) This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 5-32710680-G-A is Benign according to our data. Variant chr5-32710680-G-A is described in ClinVar as [Benign]. Clinvar id is 3058216.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 55 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPR3 | NM_001363652.2 | c.18G>A | p.Leu6= | synonymous_variant | 1/8 | ||
NPR3 | NM_001204376.2 | c.18G>A | p.Leu6= | synonymous_variant | 1/8 | ||
NPR3 | NM_001364460.2 | c.18G>A | p.Leu6= | synonymous_variant | 1/7 | ||
NPR3 | NM_001364458.2 | c.50-14018G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPR3 | ENST00000506712.1 | n.27G>A | non_coding_transcript_exon_variant | 1/6 | 1 | ||||
NPR3 | ENST00000434067.6 | c.18G>A | p.Leu6= | synonymous_variant | 1/8 | 5 | |||
NPR3 | ENST00000326958.5 | c.18G>A | p.Leu6= | synonymous_variant | 1/8 | 2 | |||
NPR3 | ENST00000509104.5 | c.101-14018G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152176Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
55
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00163 AC: 225AN: 137864Hom.: 4 AF XY: 0.00219 AC XY: 163AN XY: 74444
GnomAD3 exomes
AF:
AC:
225
AN:
137864
Hom.:
AF XY:
AC XY:
163
AN XY:
74444
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000608 AC: 844AN: 1388366Hom.: 11 Cov.: 31 AF XY: 0.000886 AC XY: 606AN XY: 684256
GnomAD4 exome
AF:
AC:
844
AN:
1388366
Hom.:
Cov.:
31
AF XY:
AC XY:
606
AN XY:
684256
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000361 AC: 55AN: 152294Hom.: 1 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74456
GnomAD4 genome
AF:
AC:
55
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
41
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NPR3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at